The magnitudes of faecal secretory IgA responses against all antigens in infants aged 6–11 months were significantly higher in vaccinees than placebo recipients (only against CFA/I, CS3, and LTB after Holm's Bonferroni adjustment), even in infants without a positive ALS response (figure 2A). This evidence concerns the gene CD79A and amyotrophic lateral sclerosis.